038460 — BioSmart Co Balance Sheet

0.000.00%

Last trade - 00:00

TechnologySpeculativeSmall CapNeutral

Market Cap
KR₩109bn
Enterprise Value
KR₩166bn
Revenue
KR₩456bn

Annual balance sheet for BioSmart Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	40,128	18,558	15,274	20,282	31,343
Net Total Accounts Receivable
Net Total Receivables	23,463	24,337	42,556	42,347	41,319
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	102,267	86,837	118,957	129,647	135,287
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	25,375	29,943	52,866	50,080	45,029
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	183,544	168,228	225,851	237,183	260,063
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	61,146	60,736	91,458	131,181	120,305
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	78,077	71,450	126,753	140,458	148,372
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	105,466	96,779	99,098	96,725	111,691
Total Liabilities & Shareholders' Equity	183,544	168,228	225,851	237,183	260,063
Total Common Shares Outstanding